PyInvesting

Market research

002004.SHE Huapont Life Sciences Co., Ltd

SHE CNY Basic Materials

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
9B
P/E ratio
13.64
Analyst target
12
Dividend yield
5.5%
Beta
0.26

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Huapont Life Sciences Co., Ltd is currently in a long term uptrend where the price is trading 1.6% above its 200 day moving average.

From a valuation standpoint, the stock is 89.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.

Huapont Life Sciences Co., Ltd's total revenue rose by 15.1% to $3B since the same quarter in the previous year.

Its net income has increased by 21.7% to $138M since the same quarter in the previous year.

Finally, its free cash flow grew by 35.2% to $396M since the same quarter in the previous year.

Based on the above factors, Huapont Life Sciences Co., Ltd gets an overall score of 5/5.